• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

ITD Daily share buy-back notice - Appendix 3E14/11/17
ITD Launch of ITL Clinical and ITL EssentialsPRICE SENSITIVE13/11/17
ITD Daily share buy-back notice - Appendix 3E13/11/17
ITD Daily share buy-back notice - Appendix 3E10/11/17
ITD Notice of Annual General Meeting/Proxy Form30/10/17
ITD Final share buy-back notice - Appendix 3F27/10/17
ITD Announcement of buy-back - Appendix 3C25/10/17
ITD ITL BRR Interview19/10/17
ITD Henslo Initiates Research Coverage09/10/17
ITD Appendix 3B New Share Issue04/10/17
ITD Sale of Custom Pack Business for $14.4mPRICE SENSITIVE03/10/17
ITD Trading HaltPRICE SENSITIVE02/10/17
ITD ITL Boardroom Media Interview21/08/17
ITD ITL Limited Announces Positive Full Year Results21/08/17
ITD ITL Corporate Governance Statement21/08/17
ITD ITL Appendix 4G21/08/17
ITD ITL Appendix 4E & Annual Report 2017PRICE SENSITIVE21/08/17
ITD Change of Director's Interest Notice01/08/17
ITD Change of Director's Interest Notice01/08/17
ITD Change of Director's Interest Notice01/08/17
ITD Appendix 3B01/08/17
ITD ITL Wins SSK Contract Extension with US Blood BankPRICE SENSITIVE25/07/17
ITD National Diabetes Week drives demand for MyHealthTest18/07/17
ITD Largest South American Blood Center initiates use of SSK13/07/17
ITD BRR Interview with MyHealthTest11/07/17
ITD MHT in World First Diabetes Prevention ProgramPRICE SENSITIVE11/07/17
ITD MyHealthTest awarded $2.6m CRC Project GrantPRICE SENSITIVE28/06/17
ITD ITL HealthGroup Investment Conference Presentation22/06/17
ITD Change of Director's Interest Notice22/06/17
ITD Change of Director's Interest Notice22/06/17
ITD Change of Director's Interest Notice22/06/17
ITD Appendix 3B22/06/17
ITD TBF ceases to be substantial holder19/06/17
ITD ITL Boardroom Interview - Results Update14/06/17
ITD ITL Trading UpdatePRICE SENSITIVE14/06/17
ITD ITL Investor Update15/05/17
ITD MyHealthTest Achieves Laboratory AccreditationPRICE SENSITIVE02/05/17
ITD ITL awarded Supply Agreement with NZ Blood ServicePRICE SENSITIVE19/04/17
ITD ITL Achieves Record MonthPRICE SENSITIVE28/03/17
ITD ITL Global rebrand to ITL Health Group27/02/17
ITD Substantial Holding in ITL Notice - TBF20/02/17
ITD Boardroom Radio Interview Mr Bill Mobbs CEO ITL20/02/17
ITD ITL Corporate & BioMedical Growth Update20/02/17
ITD ITL Profit Doubles in Half Year 2016-17 Results17/02/17
ITD ITL Appendix 4D & Financial Statements Dec 2016PRICE SENSITIVE17/02/17
ITD ITL brings on Specialist Small Cap Funds Manager23/12/16
ITD Change in Interest/Substantial Holdings Notice23/12/16
ITD Change of Director's Interest Notice23/12/16
ITD ITL Innovations Newsletter Release16/12/16
ITD ITL announces Distribution Agreement with bioMerieux CanadaPRICE SENSITIVE05/12/16
ITD ITL Limited Application for quotation of shares released02/12/16
ITD MyHealthTest Innovation GrantPRICE SENSITIVE30/11/16
ITD Final share buy-back notice - Appendix 3F28/11/16
ITD ITL Limited appendix 3C Buyback AnnouncementPRICE SENSITIVE16/11/16
ITD Release of Shares from Escrow - ITL Limited14/11/16
ITD Significant Sales of DonorCare Needle Guard 2 - ITL LimitedPRICE SENSITIVE07/11/16
ITD BRR interview following AGM and Positive Q1-ITL Limited-ITD.AX 28/10/16
ITD ITL Limited Results of 2016 AGM-ITD.AX 28/10/16
ITD ITL Limited Chairman's Presentation to AGM 2016-ITD.AX PRICE SENSITIVE27/10/16
ITD ITL announces Global Launch of Donor Care Needle Guard 2-ITD.AX PRICE SENSITIVE24/10/16
ITD ITL Announces Global SSK Distribution Agreement-ITD.AX PRICE SENSITIVE17/10/16
ITD ITL's SampLok Sampling System in multi-year NHSBT tender-ITD.AX PRICE SENSITIVE10/10/16
ITD ITL 5 Year Contract with Macquarie University Hospital-ITD.AX PRICE SENSITIVE30/09/16
ITD ITL Annonuces Contract with Barwon Health-ITD.AX PRICE SENSITIVE20/09/16
ITD Notice of General Meeting/Proxy Form-ITD.AX 12/09/16
ITD New Contract for ITL's Innovative IV Starter Kit-ITD.AX PRICE SENSITIVE05/09/16
ITD ITL Announces Contract Extension with Austin Health-ITD.AX PRICE SENSITIVE31/08/16
ITD ITL Ranked 16th most Innovative-ITD.AX 23/08/16
ITD Appendix 3Y - Change of Director's Interest Notice ITL-ITD.AX 23/08/16
ITD ITL Limited Appendix 3B-ITD.AX 23/08/16
ITD ITL Limited Announces 2015/16 Results-ITD.AX 23/08/16
ITD ITL Limited Corporate Governance Statememt-ITD.AX 23/08/16
ITD ITL Limited Appendix 4G-ITD.AX 23/08/16
ITD ITL Limited Appx 4E & 2016 Annual Report-ITD.AX PRICE SENSITIVE23/08/16
ITD ITL contract extension with bioMerieux-ITD.AX PRICE SENSITIVE08/08/16
ITD ITL wins SSK Contract Extension correction-ITD.AX PRICE SENSITIVE08/07/16
ITD ITL wins SSK Contract Extension-ITD.AX PRICE SENSITIVE07/07/16
ITD Appendix 3B ITL Limited-ITD.AX 22/06/16
ITD ITL Limited Corporate Update-ITD.AX PRICE SENSITIVE21/06/16
ITD ITL Limited Change of CFO-ITD.AX 08/06/16
ITD ITL US Customer ExpansionPRICE SENSITIVE21/03/16
ITD MHT accepted into HCF Health Technology Accelerator Program16/03/16
ITD ITL announces MyHealthTest distribution into PharmaciesPRICE SENSITIVE08/03/16
ITD ITL Limited Share Cancellation01/03/16
ITD ITL Limited announce Taiwan FDA ApprovalPRICE SENSITIVE29/02/16
ITD ITL Limited Corporate UpdatePRICE SENSITIVE22/02/16
ITD ITL Limited Announces Half Year 2015/16 Results17/02/16
ITD ITL Limited Appendix 4D Half Yearly ReportPRICE SENSITIVE17/02/16
ITD Daily share buy-back notice - Appendix 3E09/02/16
ITD Daily share buy-back notice - Appendix 3E08/02/16
ITD ITL Limited Granted Important US PatentPRICE SENSITIVE20/01/16
ITD ITL Limited Appendix 3B 1 December 201502/12/15
ITD Change of Director's Interest Notice01/12/15
ITD Change of Interest of Substantial Holder01/12/15
ITD ITL Announces Completion of MHT Acquisition01/12/15
ITD ITL Limited New Share Announcement Appx 3B01/12/15
ITD Announcement of buy-back - Appendix 3CPRICE SENSITIVE27/11/15
ITD ITL Limited - Results of AGM 201526/11/15
ITD Chairman's Presentation AGM ITL Limited26/11/15
ITD Final share buy-back notice - Appendix 3F30/10/15
ITD Daily share buy-back notice - Appendix 3E
14/11/17
ITD Launch of ITL Clinical and ITL Essentials
13/11/17PRICE SENSITIVE
ITD Daily share buy-back notice - Appendix 3E
13/11/17
ITD Daily share buy-back notice - Appendix 3E
10/11/17
ITD Notice of Annual General Meeting/Proxy Form
30/10/17
ITD Final share buy-back notice - Appendix 3F
27/10/17
ITD Announcement of buy-back - Appendix 3C
25/10/17
ITD ITL BRR Interview
19/10/17
ITD Henslo Initiates Research Coverage
09/10/17
ITD Appendix 3B New Share Issue
04/10/17
ITD Sale of Custom Pack Business for $14.4m
03/10/17PRICE SENSITIVE
ITD Trading Halt
02/10/17PRICE SENSITIVE
ITD ITL Boardroom Media Interview
21/08/17
ITD ITL Limited Announces Positive Full Year Results
21/08/17
ITD ITL Corporate Governance Statement
21/08/17
ITD ITL Appendix 4G
21/08/17
ITD ITL Appendix 4E & Annual Report 2017
21/08/17PRICE SENSITIVE
ITD Change of Director's Interest Notice
01/08/17
ITD Change of Director's Interest Notice
01/08/17
ITD Change of Director's Interest Notice
01/08/17
ITD Appendix 3B
01/08/17
ITD ITL Wins SSK Contract Extension with US Blood Bank
25/07/17PRICE SENSITIVE
ITD National Diabetes Week drives demand for MyHealthTest
18/07/17
ITD Largest South American Blood Center initiates use of SSK
13/07/17
ITD BRR Interview with MyHealthTest
11/07/17
ITD MHT in World First Diabetes Prevention Program
11/07/17PRICE SENSITIVE
ITD MyHealthTest awarded $2.6m CRC Project Grant
28/06/17PRICE SENSITIVE
ITD ITL HealthGroup Investment Conference Presentation
22/06/17
ITD Change of Director's Interest Notice
22/06/17
ITD Change of Director's Interest Notice
22/06/17
ITD Change of Director's Interest Notice
22/06/17
ITD Appendix 3B
22/06/17
ITD TBF ceases to be substantial holder
19/06/17
ITD ITL Boardroom Interview - Results Update
14/06/17
ITD ITL Trading Update
14/06/17PRICE SENSITIVE
ITD ITL Investor Update
15/05/17
ITD MyHealthTest Achieves Laboratory Accreditation
02/05/17PRICE SENSITIVE
ITD ITL awarded Supply Agreement with NZ Blood Service
19/04/17PRICE SENSITIVE
ITD ITL Achieves Record Month
28/03/17PRICE SENSITIVE
ITD ITL Global rebrand to ITL Health Group
27/02/17
ITD Substantial Holding in ITL Notice - TBF
20/02/17
ITD Boardroom Radio Interview Mr Bill Mobbs CEO ITL
20/02/17
ITD ITL Corporate & BioMedical Growth Update
20/02/17
ITD ITL Profit Doubles in Half Year 2016-17 Results
17/02/17
ITD ITL Appendix 4D & Financial Statements Dec 2016
17/02/17PRICE SENSITIVE
ITD ITL brings on Specialist Small Cap Funds Manager
23/12/16
ITD Change in Interest/Substantial Holdings Notice
23/12/16
ITD Change of Director's Interest Notice
23/12/16
ITD ITL Innovations Newsletter Release
16/12/16
ITD ITL announces Distribution Agreement with bioMerieux Canada
05/12/16PRICE SENSITIVE
ITD ITL Limited Application for quotation of shares released
02/12/16
ITD MyHealthTest Innovation Grant
30/11/16PRICE SENSITIVE
ITD Final share buy-back notice - Appendix 3F
28/11/16
ITD ITL Limited appendix 3C Buyback Announcement
16/11/16PRICE SENSITIVE
ITD Release of Shares from Escrow - ITL Limited
14/11/16
ITD Significant Sales of DonorCare Needle Guard 2 - ITL Limited
07/11/16PRICE SENSITIVE
ITD BRR interview following AGM and Positive Q1-ITL Limited-ITD.AX
28/10/16
ITD ITL Limited Results of 2016 AGM-ITD.AX
28/10/16
ITD ITL Limited Chairman's Presentation to AGM 2016-ITD.AX
27/10/16PRICE SENSITIVE
ITD ITL announces Global Launch of Donor Care Needle Guard 2-ITD.AX
24/10/16PRICE SENSITIVE
ITD ITL Announces Global SSK Distribution Agreement-ITD.AX
17/10/16PRICE SENSITIVE
ITD ITL's SampLok Sampling System in multi-year NHSBT tender-ITD.AX
10/10/16PRICE SENSITIVE
ITD ITL 5 Year Contract with Macquarie University Hospital-ITD.AX
30/09/16PRICE SENSITIVE
ITD ITL Annonuces Contract with Barwon Health-ITD.AX
20/09/16PRICE SENSITIVE
ITD Notice of General Meeting/Proxy Form-ITD.AX
12/09/16
ITD New Contract for ITL's Innovative IV Starter Kit-ITD.AX
05/09/16PRICE SENSITIVE
ITD ITL Announces Contract Extension with Austin Health-ITD.AX
31/08/16PRICE SENSITIVE
ITD ITL Ranked 16th most Innovative-ITD.AX
23/08/16
ITD Appendix 3Y - Change of Director's Interest Notice ITL-ITD.AX
23/08/16
ITD ITL Limited Appendix 3B-ITD.AX
23/08/16
ITD ITL Limited Announces 2015/16 Results-ITD.AX
23/08/16
ITD ITL Limited Corporate Governance Statememt-ITD.AX
23/08/16
ITD ITL Limited Appendix 4G-ITD.AX
23/08/16
ITD ITL Limited Appx 4E & 2016 Annual Report-ITD.AX
23/08/16PRICE SENSITIVE
ITD ITL contract extension with bioMerieux-ITD.AX
08/08/16PRICE SENSITIVE
ITD ITL wins SSK Contract Extension correction-ITD.AX
08/07/16PRICE SENSITIVE
ITD ITL wins SSK Contract Extension-ITD.AX
07/07/16PRICE SENSITIVE
ITD Appendix 3B ITL Limited-ITD.AX
22/06/16
ITD ITL Limited Corporate Update-ITD.AX
21/06/16PRICE SENSITIVE
ITD ITL Limited Change of CFO-ITD.AX
08/06/16
ITD ITL US Customer Expansion
21/03/16PRICE SENSITIVE
ITD MHT accepted into HCF Health Technology Accelerator Program
16/03/16
ITD ITL announces MyHealthTest distribution into Pharmacies
08/03/16PRICE SENSITIVE
ITD ITL Limited Share Cancellation
01/03/16
ITD ITL Limited announce Taiwan FDA Approval
29/02/16PRICE SENSITIVE
ITD ITL Limited Corporate Update
22/02/16PRICE SENSITIVE
ITD ITL Limited Announces Half Year 2015/16 Results
17/02/16
ITD ITL Limited Appendix 4D Half Yearly Report
17/02/16PRICE SENSITIVE
ITD Daily share buy-back notice - Appendix 3E
09/02/16
ITD Daily share buy-back notice - Appendix 3E
08/02/16
ITD ITL Limited Granted Important US Patent
20/01/16PRICE SENSITIVE
ITD ITL Limited Appendix 3B 1 December 2015
02/12/15
ITD Change of Director's Interest Notice
01/12/15
ITD Change of Interest of Substantial Holder
01/12/15
ITD ITL Announces Completion of MHT Acquisition
01/12/15
ITD ITL Limited New Share Announcement Appx 3B
01/12/15
ITD Announcement of buy-back - Appendix 3C
27/11/15PRICE SENSITIVE
ITD ITL Limited - Results of AGM 2015
26/11/15
ITD Chairman's Presentation AGM ITL Limited
26/11/15
ITD Final share buy-back notice - Appendix 3F
30/10/15
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.